UNITED STATES SECURITIES AND EXCHANGE COMMISSION  WASHINGTON, D.C. 20549  FORM 10-QSB/A  [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2004  [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from __________________ to __________________  Commission File Number 0-23957   MEDITECNIC, INC. (Exact Name of small business issuer as specified in its charter)  Nevada 87-0430532 (State or other Jurisdiction of I.R.S. Employer Identi- Incorporation or Organization fication No.)  24351 Pasto Road, #B, Dana Point, California 92629 (Address of Principal Executive Offices) (Zip Code)  (949) 489-2400 (Issuer's Telephone Number, including Area Code)  Indicate by check mark whether the Registrant (i) has filed all reports required to be filed by Section 13, or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (of for such shorter period that the Registrant was required to file such reports) and (ii) has been subject to such filing requirements for the past 90 days.  YesNo X Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. YesNo __X__ Indicate the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date.  Common Stock, par value  $.001 7,527,485 Title of Class Number of Shares outstanding at October 6, 2008 Transitional Small Business Format     Yes     No X       MEDITECNIC, INC. (A DEVELOPMENT STAGE COMPANY) BALANCE SHEET AS OF MARCH 31, 2004 AND DECEMBER 31, 2003  March 31 December 31 ASSETS 2004 2003  Current Assets Cash and Cash Equivalents $ 48,177 $ 161,658 Interest Receivable 15,108 38,741 Accounts Receivable (3,886) -- Inventory 103,365 -- Prepaid Expenses -- -- Marketable Securities (Note B) 25,240 96,030 Total Current Assets $ 188,004 $ 296,429  Fixed Assets Vehicles 15,774 15,774 Office Furniture 17,871 17,871 Office Equipment 56,340 56,340 Data Processing Equipment 38,980 20,681 Equipment Installation 43,362 49,044 Organization Costs 23,449 23,449 195,776 183,159 Accumulated Depreciation (134,962) (130,608) Total Fixed Assets 60,814 52,551  Other Assets Patents (Note C) 637,260 637,260 Research and Development 38,377 62,120 Deposits (Note I) 234,066 241,121 Total Other Assets 909,703 940,501  Total Assets $ 1.158,521 $ 1,289,481  LIABILIITES AND STOCKHOLDERS EQUITY Current Liabilities Accounts Payable 157,039 198,796 Accrued Payroll Taxes -- 18,114 Loans from Shareholders 829,472 719,472 Total Current Liabilities 986,511 936,382  Stockholders Equity Preferred Stock (1,000 shares issued and outstanding) 1 1 Capital Stock (7,527,485 issued and outstanding) 7,528 7,528 Additional Paid In Capital 3,495,072 3,495,072 Accumulated Deficit During the Development Stage (3,370,766) (3,165,980) Accumulated Other Comprehensive Income 40,176 16,477 172,010 353,099  Total Liabilities and Stockholders Equity $ 1,158,521 $ 1,289,481  See accompanying Notes to Financial Statements.      MEDITECNIC, INC. (A DEVELOPMENT STAGE COMPANY) STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2004 AND 2003 AND CUMULATIVE FROM MARCH 24, 1998 TO MARCH 31, 2004 Cumulative March 31 March 31 1998 TO Income 2004 2003 2004 Sales Turnover $ -- $ -- $ 258,814 Research and Development -- -- 357,332 Realization of Patents -- -- 90,734 Other Revenue 51 2,477 14,081 Total Income 51 2,477 720,961 Operating Expenses General and Administrative 4,000 10,595 263,205 Bank Charges 138 433 48,937 Audit Fees -- 2,500 30,475 Marketing and Advertising 4,285 1,466 16,165 Other Financial Charges -- -- 55,877 Legal and Honoraries 16,925 2,891 45,911 Research and Development 23,136 -- 1,072,980 Translation Fees -- -- 3,619 Patent Fees -- 45,181 521,474 Travel -- 7,286 101,989 Depreciation 4,354 4,054 134,962 Amortization 15,438 29,525 470,913 Staff Research 41,384 57,885 820,361 Office Expenses 1,343 1,654 39,421 Vehicle Expense 1,704 -- 4,507 Entertainment -- 4,315 17,258 Small Materials and Supplies -- -- 69,490 Postage and Delivery 301 192 1,710 Insurance  Business 4,507 681 15,262 Promotions and Seminars 6,660 2,491 82,630 Telephone 677 315 8,602 Office Rent 30,441 23,142 171,609 Utilities -- -- 318 Repairs and Maintenance -- 108 1,741 Payroll Taxes 37,149 7,900 99,129 Total Operating Expenses 192,442 202,614 4,098,545 Net Operating Income (Loss) (192,391) (200,137) (3,377,584) Other Income (Expense) Interest Income -- -- 38,607 Insurance Indemnities -- -- 10,658 Interest Expense (463) (2,237) (14,571) Other Taxes (11,933) (519) (27,786) Total Other Income (Expense) (12,396) (2,756) 6,818 Net Income (Loss) $ (204,787) $ (202,893) $ (3,370,766) Other Comprehensive Income (Loss) Gains (Losses) on Exchange Rates (16,517) (6,917) (56,166) Change in Value of Life Insurance -- -- 12,744 Gain (Loss) in Marketable Securities 40,216 7,277 83,598 Net Comprehensive Income (Loss) 23,699 360 40,176  Net Income (Loss) per share $ (0) $ (0.0270) $ -- See accompanying Notes to Financial Statements.       MEDITECNIC, INC. (A DEVELOPMENT STAGE COMPANY) STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2004 AND 2003 AND CUMULATIVE FROM MARCH 24, 1998 TO MARCH 31, 2004  Cumulative March 31 March 31 1998 TO CASH FLOWS FROM OPERATING ACTIVITIES 2004 2003 2004 Net Income $ (204,787) $ (202,893) $ (3,370,766)  Adjustments to reconcile net income to net cash provided by operating activities Depreciation 4,354 4,054 134,964 Amortization 15,438 29,525 470,913 Increase (decrease) in: Interest Receivable 23,633 -- (15,108) Accounts Receivable 3,886 -- 3,886 Prepaid Expenses -- -- -- Inventory (103,365) -- (103,365) Research and Development 8,277 -- (509,318) Increase (decrease) in: Accounts Payable (41,757) 16,079 157,039 Accrued Liabilities (18,114) (26,662) -- Other Comprehensive Income 23,699 -- 40,176 Net Cash Provided (Used) By Operating Activities (288,736) (179,897) (3,191,579)  CASH FLOWS FROM INVESTING ACTIVITIES  Cash Used for Deposit 7,055 -- (234,068) Cash Used of Patent Acquisition -- (110,706) (637,260) Acquisition of Fixed Assets (12,617) -- (195,776) Increase (decrease) in Marketable Securities 70,790 26,600 (25,213) Net Cash (Used) By Investing Activities 65,288 (84,106) (1,092,317)  CASH FLOWS FROM FINANCING ACTIVITIES  Loans From Shareholders 110,000 -- 829,472 Sale of Common Stock -- -- 3,502,601 Net Cash (Used) By Financing Activities 110,000 -- 4,332,073  NET INCREASE (DECREASE) IN CASH (113,508) (264,003) 48,177  CASH AT BEGINNING OF PERIOD 161,685 740,278 --  CASH AT END OF PERIOD $ 48,177 $ 476,275 $ 48,177  Cash Paid for Interest 463 -- 7,764      See accompanying Notes to Financial Statements.       MEDITECNIC, INC. (A Development Stage Company) NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED) MARCH 31, 2004   Item 1.       Comments  The accompanying financial statements are unaudited, but in the opinion of the management of the Company, contain all adjustments, consisting of only normal recurring accruals, necessary to present fairly the financial position at March 31, 2004, the results of operations for the three months ended March 31,  2004 and 2003, and the cash flows for the three months ended March 31, 2004 and 2003.  Reference is made to the Company's Form 10-KSB for the year ended December 31, 2003.  The results of operations for the three months ended March 31, 2003 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2004.  Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION  The Company had no sales in the three months ended March31, 2004 and 2003, respectively. Our net loss was $204,787 and $202,893 for the three months ended March 31, 2004 and 2003, respectively.  The Company invests cash in marketable securities. A portion of the Companys current assets are valued in currencies other than the US dollar, primarily Swiss francs. We recognize gains and losses on the currency exchange rate changes from time to time.  The Company had cash on hand and marketable securities of $73,417 at March 31, 2004, which is believed, together with loans from shareholders,  to be sufficient to fund the Companys operations until at least the end of fiscal 2004. An additional $110,000 was loaned by shareholders in the quarter.  Information included in this  report  includes forward looking statements, which can be identified by the use of forward-looking terminology such as may, expect, anticipate, believe, estimate, or continue, or the negative thereof or other variations thereon or comparable terminology. The statements in "Risk Factors" and other statements and disclaimers in this registration statement constitute cautionary statements identifying important factors, including risks and uncertainties, relating to the forward-looking statements that could cause actual results to differ materially from those reflected in the forward-looking statements.  Since we have not yet generated any revenues, we are a development stage company as that term is defined in paragraphs 8 and 9 of SFAS No. 7.   Our auditors have included an explanatory paragraph in their report on our financial statements, relating to the uncertainty of our business as a going concern, due to our lack of operating history or current revenues and competitive position.  We do not believe that conventional financing, such as bank loans, is available to us due to these factors.  We have no bank line of credit available to us.  Management believes that it will be able to raise the required funds for operations from one or more future offerings, in order to effect our business plan.  Our future operating results are subject to many facilities, including:  o     our success in developing our technology;  o     our ability to obtain customers for our devices;  o     the effects of competition;  o     our ability to obtain additional financing; and  o     other risks which we identify in future filings with the SEC.  Any or all of our forward looking statements in this annual report and in any other public statement we make may turn out to be wrong. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Consequently, no forward looking statement can be guaranteed. In addition, we undertake no responsibility to update any forward-looking statement to reflect events or circumstances which occur after the date of this report.  PART II.  OTHER INFORMATION  Item 1. LEGAL PROCEEDINGS  -  None  Item 2. CHANGES IN SECURITIES - None  Item 3. DEFAULTS UPON SENIOR SECURITIES - None  Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS - None  Item 5. OTHER INFORMATION - None  Item 6. EXHIBITS --None        SIGNATURES  Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   MEDITECNIC, INC.    Date: October 6, 2008 By:/s/ Luc Badel Luc Badel Treasurer (chief financial officer and accounting officer and duly authorized officer)